```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 2317 Introduced in Senate (IS)]

<DOC>

115th CONGRESS
  2d Session
                                S. 2317

   To amend the Controlled Substances Act to provide for additional 
 flexibility with respect to medication-assisted treatment for opioid 
                 use disorders, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 17, 2018

    Mr. Markey (for himself, Mr. Paul, Ms. Hassan, and Ms. Collins) 
introduced the following bill; which was read twice and referred to the 
          Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
   To amend the Controlled Substances Act to provide for additional 
 flexibility with respect to medication-assisted treatment for opioid 
                 use disorders, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Addiction Treatment Access 
Improvement Act of 2018''.

SEC. 2. ALLOWING FOR MORE FLEXIBILITY WITH RESPECT TO MEDICATION-
              ASSISTED TREATMENT FOR OPIOID USE DISORDERS.

    (a) Conforming Applicable Number.--Subclause (II) of section 
303(g)(2)(B)(iii) of the Controlled Substances Act (21 U.S.C. 
823(g)(2)(B)(iii)) is amended to read as follows:
            ``(II) The applicable number is--
                    ``(aa) 100 if, not sooner than 1 year after the 
                date on which the practitioner submitted the initial 
                notification, the practitioner submits a second 
                notification to the Secretary of the need and intent of 
                the practitioner to treat up to 100 patients; or
                    ``(bb) 275 if the practitioner meets the 
                requirements specified in section 8.610 of title 42, 
                Code of Federal Regulations (or successor 
                regulations).''.
    (b) Eliminating Any Time Limitation for Nurse Practitioners, 
Clinical Nurse Specialists, Certified Registered Nurse Anesthetists, 
Certified Nurse Midwives, and Physician Assistants To Become Qualifying 
Practitioners.--Section 303(g)(2)(G)(iii)(II) of the Controlled 
Substances Act (21 U.S.C. 823(g)(2)(G)(iii)(II)) is amended by striking 
``during the period beginning on the date of enactment of the 
Comprehensive Addiction and Recovery Act of 2016 and ending on October 
1, 2021'' and inserting ``beginning on the date of enactment of the 
Comprehensive Addiction and Recovery Act of 2016''.
    (c) Definition of Qualifying Other Practitioner.--Clause (iv) of 
section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 
823(g)(2)(G)) is amended by striking ``nurse practitioner or physician 
assistant'' each place it appears and inserting ``nurse practitioner, 
clinical nurse specialist, certified registered nurse anesthetist, 
certified nurse midwife, or physician assistant''.
                                 <all>
```